Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis [Phase 1]
The document reports termination of a Phase 1 study evaluating AMG 357 in females with rheumatoid arthritis, focusing on safety, tolerabilit…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523 [Phase 1]
Phase 1 study of HMPL-523 in rheumatoid arthritis has completed, assessing safety, tolerability, and pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Iyengar Yoga for Young People With Rheumatoid Arthritis [NA]
ClinicalTrials.gov reports that the trial evaluating Iyengar Yoga in young people with rheumatoid arthritis has completed and posted results…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: Long-term Clinical Effectiveness of the Delta Xtend Reverse Total Shoulder [NA]
A terminated long-term clinical study evaluated the effectiveness of the Delta Xtend reverse total shoulder prosthesis across several should…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)
An observational study evaluating Rituximab (Rituxan/MabThera) in seropositive rheumatoid arthritis patients who did not respond to or could…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis [Phase 2]
A Phase 2 dose-ranging trial (VELVET) evaluating veltuzumab in adults with moderate to severe rheumatoid arthritis was terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: A Randomised Trial Comparing Anterior Versus Posterior Approach in Total Hip Replacement [NA]
The randomized trial comparing anterior versus posterior approach in total hip replacement has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis [Phase 2]
This Phase 2 trial provides long-term safety data for ATN-103 in rheumatoid arthritis patients and has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis [Phase 3]
This update summarizes a Phase 3 study of NI-071 in rheumatoid arthritis, noting that the trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: Sarilumab Effect on the Pharmacokinetics of Simvastatin [Phase 1]
Phase 1 study investigating the pharmacokinetic interaction between sarilumab and simvastatin in rheumatoid arthritis patients; results summ…
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS) [Phase 4]
Phase 4 clinical trial update on rituximab for rheumatoid arthritis patients who are non-responsive to DMARDs in Pakistan (PARIS study); the…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Activity Limitations in Rheumatoid Arthritis
A clinical trial evaluating activity limitations in rheumatoid arthritis has completed. The study was sponsored by the Federal University of…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy
A completed clinical trial evaluated the safety, tolerability and efficacy of tocilizumab in rheumatoid arthritis patients who had an inadeq…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy
This is a completed observational clinical-practice study examining how patients with rheumatoid arthritis are managed when treated with bio…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: A Study of Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDs [Phase 3]
A Phase 3 trial evaluating tocilizumab in rheumatoid arthritis patients who had an inadequate response to non-biologic DMARDs has completed,…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNF [Phase 3]
Phase 3 study of tocilizumab (RoActemra/Actemra) in rheumatoid arthritis patients with inadequate response to DMARDs or anti-TNF therapy com…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis [Phase 1]
Phase 1, single-dose study evaluating the safety of sarilumab and tocilizumab in rheumatoid arthritis. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis
This document reports the completion of a non-interventional study of RoActemra/Actemra in adults with moderate to severe rheumatoid arthrit…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA) [Phase 1, Phase 2]
A Phase 1/2 study of ocrelizumab in adults with moderate to severe rheumatoid arthritis was terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial evaluating the addition of rituximab to leflunomide in patients with active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis [Phase 4]
A Phase 4 open-label study assessed whether early response to certolizumab pegol can predict longer-term outcomes in rheumatoid arthritis; r…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Effects of Underwater Ultrasound Therapy on Hand Function and Quality of Life in Patients With Rheumatoid Arthritis [NA]
A completed clinical trial evaluated underwater ultrasound therapy for hand function and quality of life in patients with rheumatoid arthrit…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069
Update on the HOPEFUL III rheumatoid arthritis study, a follow-up survey of Study P12-069, which has completed and posted its results. The d…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)
A completed study evaluating how to manage synthetic disease-modifying antirheumatic drugs when rheumatoid arthritis patients experience adv…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis [Phase 1]
This completed Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of multiple subcutaneous injections of ABBV-257 in sub…